PCN153 - COST-EFFECTIVENESS ANALYSIS OF APALUTAMIDE FOR TREATMENT IN NON- METASTASIS CASTRATION-RESISTANT PROSTATE CANCER
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.236
https://www.valueinhealthjournal.com/article/S1098-3015(18)33536-8/fulltext
Section Title :
Section Order :
1730
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33536-8&doi=10.1016/j.jval.2018.09.236